Advertisement

Thrombosis

  • Farzana R. Bacchus
  • Mark Crowther
Chapter

Abstract

Hemostasis is a preventative mechanism for blood loss after vessel injury, while thrombosis describes the pathogenic formation of thrombi. The precise balance of procoagulant and anticoagulant mechanisms keeps blood in a fluid state while circulating, yet can rapidly respond to vascular injury through clot formation. The initial formation of the platelet plug is classically termed “primary hemostasis,” while propagation of the coagulation cascade is termed “secondary hemostasis.”

After vessel injury, platelets adhere to the exposed subendothelium via von Willebrand factor and glycoprotein (GP) Ib-IX-V on the platelet surface. Platelets become activated and secrete a number of molecules including ADP and thromboxane A2, which are platelet agonists themselves leading to further platelet activation. Platelet recruitment and aggregation occurs through binding of platelet GPIIbIIIa receptors to fibrinogen leading to formation of the platelet plug. Tissue factor (TF) in the exposed subendothelium also binds to factor VIIa with formation of the TF-FVIIa complex. The TF-FVIIa complex initiates the coagulation cascade with the ultimate production of thrombin, which is a potent agonist for platelet activation.

Chronic atherosclerotic lesions are associated with plaque formation, which, when ruptured, exposes blood to collagen and to TF in the macrophages of atheroma. There are distinct hemostatic factors in the platelet and coagulation systems that modulate atherosclerosis and have an effect on atherothrombosis. A systemic inflammatory environment leads to a proatherogenic endothelium, independent of vessel wall injury. Atherogenic mediators include cytokines, adhesion molecules like P-selectin, and TF.

Given our thorough understanding of primary and secondary hemostasis, numerous antiplatelet and anticoagulant drugs have been synthesized. This chapter reviews in detail the mechanism of action and properties of the various agents used in clinical practice and some newer experimental agents.

Keywords

International Normalize Ratio Platelet Activation Tissue Factor Prothrombin Complex Concentrate Dabigatran Etexilate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Arnold DM, Rao AK. Disorders of platelet number and function. In: Gregory SA, McCrae KR, editors. American Society of Hematology self-assessment program. 4th ed. Washington, D.C.: Cadmus Communications Corporation; 2010. p. 241–62.Google Scholar
  2. 2.
    Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31:381–92.PubMedCrossRefGoogle Scholar
  3. 3.
    Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol. 2008;28:403–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Brass LF. Thrombin and platelet activation. Chest. 2003;124:18S–25.PubMedCrossRefGoogle Scholar
  5. 5.
    Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938–49.PubMedCrossRefGoogle Scholar
  6. 6.
    Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Mann KG. Thrombin formation. Chest. 2003;124:4S–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005;3:1800–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102:248–57.PubMedGoogle Scholar
  10. 10.
    Hoffman M, Monroe III DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958–65.PubMedGoogle Scholar
  11. 11.
    Dahlback B. Blood coagulation. Lancet. 2000;355:1627–32.PubMedCrossRefGoogle Scholar
  12. 12.
    Maas C, Oschatz C, Thomas R. The plasma contact system 20. Semin Thromb Hemost. 2011;37:375–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Crawley JTB, Lane DA. The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol. 2008;28:233–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Gebbink MF. Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis. J Thromb Haemost. 2011;9 Suppl 1:174–81.PubMedCrossRefGoogle Scholar
  15. 15.
    Undas A, Ariens AS. Fibrin clot structure and function A role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol. 2011;31:e88–99.PubMedCrossRefGoogle Scholar
  16. 16.
    Borissoff JI, Spronk HMH, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364:1746–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Gailani D, Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol. 2007;27:2507–13.PubMedCrossRefGoogle Scholar
  18. 18.
    Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e89S–119.PubMedCrossRefGoogle Scholar
  19. 19.
    Patrono C, Andreotti F, Arnesen H, et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J. 2011;32:2922–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Weitz DS, Weitz JI. Update on heparin: what do we need to know? J Thromb Thrombolysis. 2010;29:199–207.PubMedCrossRefGoogle Scholar
  21. 21.
    Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e24S–43.PubMedCrossRefGoogle Scholar
  22. 22.
    Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e44S–88.PubMedCrossRefGoogle Scholar
  23. 23.
    Abraham ME, Marcy TR. Warfarin versus dabigatran: comparing the old with the new. Consult Pharm. 2012;27:121–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Bates SM, Weitz JI. The mechanism of action of thrombin inhibitors. J Invasive Cardiol. 2000;12(Suppl F):27F–32.PubMedGoogle Scholar
  25. 25.
    Lee CJ, Ansell JE. Direct thrombin inhibitors. Br J Clin Pharmacol. 2011;72:581–92.PubMedCrossRefGoogle Scholar
  26. 26.
    Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost. 2003;1:1504–14.PubMedCrossRefGoogle Scholar
  27. 27.
    Garcia D, Libby E, Crowther MA. The new oral anticoagulants. Blood. 2010;115:15–20.PubMedCrossRefGoogle Scholar
  28. 28.
    Goodman SG, Menon V, Cannon CP, Steg G, Ohman EM, Harrington RA. Acute st-segment elevation myocardial infarction: American College of Chest Physicians evidenced-based clinical practice guidelines (8th edition). Chest. 2008;133:708S–75.PubMedCrossRefGoogle Scholar

Recommended Reading

  1. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice ­guidelines. Chest. 2012;141.Google Scholar
  2. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94.PubMedCrossRefGoogle Scholar
  3. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938–49.PubMedCrossRefGoogle Scholar
  4. Garcia D, Libby E, Crowther MA. The new oral anticoagulants. Blood. 2010;115:15–20.PubMedCrossRefGoogle Scholar
  5. Lee CJ, Ansell JE. Direct thrombin inhibitors. Br J Clin Pharmacol. 2011;72:581–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of MedicineUniversity of TorontoTorontoCanada
  2. 2.Faculty of Health Sciences, St Joseph’s HospitalMcMaster UniversityHamiltonCanada

Personalised recommendations